ALRT - ALR Technologies Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0544
+0.0004 (+0.74%)
At close: 2:55PM EDT
Stock chart is not supported by your current browser
Previous Close0.0540
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume128,946
Market Cap13.207M
Beta (3Y Monthly)22.10
PE Ratio (TTM)N/A
EPS (TTM)-0.0180
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.11
Trade prices are not sourced from all markets
  • GlobeNewswire16 days ago

    ALR Technologies and IDEAS DWC LLC to Market the ALRT Diabetes Solution In the Middle East and North Africa

    ALR Technologies Inc. (ALRT) has signed a Collaboration Agreement with IDEAS DWC LLC. (“IDEAS”), a Dubai-based marketing company, to bring the ALRT Diabetes Solution to the estimated 40 million people with diabetes in the Middle East and North Africa (MENA) region. The International Diabetes Foundation reports that this regional area has the highest prevalence of diabetes in the world. Under the terms of the agreement, IDEAS will conduct all business activities on behalf of ALRT in the region and ALRT will provide all necessary support to IDEAS.

  • GlobeNewswire2 months ago

    ALR Technologies (ALRT) and Aspire Cerebro Agree to Co-Market the ALRT Diabetes Solution In India

    ALR Technologies Inc. (OTCPINK: ALRT) has signed a Memorandum of Understanding with Aspire Cerebro Advertising Ltd. to bring the ALRT Diabetes Solution to India’s estimated 100 million diabetes patients. The arrangement would connect private healthcare facilities in India with global pharmaceuticals companies and glucose test suppliers through the ALRT Diabetes Solution.

  • We're sorry this is all we were able to find about this topic.